• No results found

$349* *earlybird pricing

N/A
N/A
Protected

Academic year: 2021

Share "$349* *earlybird pricing"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

(1)

Optomax

Conference

Perth

$349*

50

Sunday 3 May 2015

McCusker Auditorium

Harry Perkins Institute

limited tickets

there’s only

*earlybird pricing

*earlybird tix

available

Registe

r now a

t optom

ax.com

.au

All your y

early th

erapeut

ic & fac

e-to-fac

e CPD p

oints in o

ne day

Work an

d family

friendly

one da

y Confer

ence

Maximum

points /

Minimum

time

31.5 Accredited CPD

Points applied for

(2)

A/Prof Angus Turner

Dr Angus Turner completed medical training at The University of Western Australia (UWA), before studying at Oxford University and completing a Masters of Evidence Based Medicine. Ophthalmology training was undertaken in Melbourne, followed by post-graduate training at University of Sydney in refractive surgical procedures. As Director of Outback Vision, Dr Turner is actively involved in the delivery of specialist outreach services to remote and Indigenous communities in the Kimberley, Pilbara, Goldfields, Great Southern, and South West regions. Dr Turner is an Associate Professor at UWA, where he is engaged in a number of research projects at the Lions Eye Institute, focusing on service delivery for remote and Indigenous people. Dr Turner is also a consultant at Fremantle Hospital and an ophthalmology teacher for the Rural Clinical School.

Speakers

A/Prof Steven Wiffen

MB BS, FRACO, FRACS

Associate Professor Wiffen trained in ophthalmology in Western Australia before undertaking fellowships at the Corneo-Plastic Unit, East Grinstead, UK, and at the Mayo Clinic, Rochester, Minnesota, USA Associate Professor Wiffen is a consultant ophthalmologist at Fremantle Hospital and a Senior Lecturer at UWA He is Director of the Lions Eye Bank of Western Australia.

Dr Jean-Louis deSousa

Dr deSousa trained in ophthalmology in Perth before completing fellowships in ophthalmic plastic and reconstructive surgery in Oxford and East Grinstead in the UK. He is a member of the Australian and New Zealand Society of Ophthalmic Plastic Surgeons. A consultant ophthalmologist at Royal Perth Hospital he also provides ophthalmic services to the central wheatbelt from Merredin. Dr deSousa is the WA representative for continuing professional development and a basic sciences examiner for RANZCO.

The Australian Institute of Optometry

C o n f e r e n c e 2 0 1 1

M a x i m u m C P D . M i n i m u m T i m e .

Prof Geoffrey Crawford

MBBS, FRANZCO, FRACS

Professor Crawford completed his ophthalmic training in Western Australia before undertaking further sub-speciality training in cornea and refractive surgery at Moorfields Eye Hospital, London, and Emory University, Atlanta, USA He is a Professor of Ophthalmology at the Centre for Ophthalmology and Visual Science, University of Western Australia He is Director of Surgical Services and a Corneal and Refractive surgeon at the Lions Eye Institute, Perth and is also a consultant ophthalmic surgeon at Royal Perth and Princess Margaret Hospitals. Professor Crawford has held many positions within RANZCO including Director of Continuing Professional Development, inaugural Chairman of the Programme Committee and Chairman of Examiners. He is a co-inventor of the AlphaCor artificial cornea and developed the techniques of its insertion. He also introduced LASIK surgery to Western Australia

Dr Andrea Ang

MBBS, MPH. Dr Ang completed her ophthalmic training in Western Australia before embarking on a Cornea, External Diseases, and Anterior Segment Fellowship at the Cincinnati Eye Institute, Ohio, USA  She is currently completing a second Cornea Fellowship at the Singapore National Eye Centre, Singapore  She was awarded a UWA Overseas Medical Fellowship and has written several publications and book chapters on ocular surface disease during her Fellowship. Her interests include ocular surface reconstruction techniques including limbal stem cell transplantation and keratoprostheses, and lamellar keratoplasty techniques, including anterior lamellar keratoplasty and Descemet’s stripping endothelial keratoplasty.

Prof Ian McAllister

Professor McAllister undertook training in Western Australia with additional sub-specialty training in vitreoretinal disorders in the USA He is Director of Clinical Services at Lions Eye Institute and a consultant ophthalmologist at King Edward Memorial Hospital for Women and the Royal Perth, Sir Charles Gairdner and Princess Margaret Hospitals. Professor McAllister is actively involved in research for cures for vitreoretinal disorders, especially retinal vascular disorders, and has held six NHMRC grants in this area He has been involved for many years in state wide diabetic retinopathy screening and treatment services and coordinates and reviews photographs from diabetic screening in remote parts of Western Australia Professor McAllister is currently vice chairman of the Ophthalmic Research Institute of Australia and has been chairman of the Research Board for many years.

A/Prof Mei-Ling Tay-Kearney

Associate Professor Tay-Kearney completed her medical training in Perth, Western Australia before pursuing postgraduate study at Johns Hopkins Hospital in Baltimore, USA In 2003 Associate Professor Tay-Kearney was appointed Head of Department of Ophthalmology at Royal Perth Hospital. She is a Senior Lecturer at UWA and a member of the Australian Society for HIV Medicine and the Australian Uveitis Study Group. She is the Chair of Qualifications and Education as well as an Examiner for the RANZCO Part 2 College examinations.

(3)

Dr Antonio Giubilato

Dr Antonio Giubilato underwent specialty fellowship training in glaucoma at the Royal Victorian Eye and Ear Hospital after training in ophthalmology in Perth, Western Australia. This included both clinical and surgical management of glaucoma as well as research into new therapies for the condition. He is presently consultant ophthalmologist in the Glaucoma Clinic at Royal Perth Hospital and also consults at Bentley Hospital for public patients. Dr Giubilato is currently Director of Training for the WA branch of RANZCO and an LSSF Board Member.

Dr Vignesh Raja

Dr. Vignesh Raja is a consultant ophthalmologist and vitreo-retinal surgeon at the Sir Charles Gairdner Hospital (SCGH). He has recently been appointed as the Head of Department of Ophthalmology at SCGH. Dr. Raja undertook his primary medical degree in India and completed his 3-year Masters in Ophthalmology from the world’s largest eye care system – the Aravind Eye Hospital and Postgraduate Institute of Ophthalmology. He pursued further specialist registrar training in Ophthalmology in the United Kingdom from 2004 -2012, completing fellowships in glaucoma and vitreo-retinal surgery at Liverpool and Oxford respectively. Dr. Raja moved to Perth in 2013 to do his second fellowship in medical and surgical retina with Prof. Ian Constable at SCGH and the Lion’s Eye Institute. In August 2014, Dr. Raja commenced private practice at the Joondalup Eye Clinic where he offers specialist consultations and treatments for cataract, glaucoma and medical & surgical retinal conditions.

Prof Ian Constable

Professor Ian Constable AO was the Lions Foundation Professor of Ophthalmology at the University of Western Australia 1975-2008 and continues to work as a Professor at that University. His principal interests are surgery of the retina and cataract as well as diagnosis and management of medical retinal conditions. He is Past President of the Asia Pacific Academy of Ophthalmology and the Asia Pacific Vitreoretinal Society and is the founding Chairman of the Asia Pacific Association of Ophthalmology Professors. He has published over 400 peer-reviewed articles and was the Chairman of the WA State Science Council from 2000 to 2006. He continues a busy clinical practice based at the Lions Eye Institute and Sir Charles Gairdner Hospital.

Talk Synopsis

Retinal vein occlusion: pathogenesis, treatments and trials

Prof Ian McAllister

This lecture will cover new treatment techniques in the management

in retinal vein occlusion will cover the current approaches with their

advantages and disadvantages. It will also examine how techniques

can be modified in the future to produce more reliable and safer

visual results.

“Doctor, what is wrong with my eye?”

A/Prof Mei-Ling Tay-Kearney

Inflammatory eye disease grand rounds, diagnosis and management

Analysis of the optic nerve in glaucoma using OCT

Dr Vignesh Raja

This talk will focus on the diagnostic capability and pitfalls of

analysis of the optic nerve head in glaucoma using OCT technology,

mainly the Cirrus HD-OCT and the Heidelberg Spectralis. This talk

aims to highlight new parameters used in the evaluation of the

glaucomatous optic nerve head and its significance in day-to-day

practice.

Gene therapy development in the context of wet macular

degeneration

Prof Ian Constable

Wet AMD provides a crucial link between Optometry and

Ophthalmology as it demands prompt diagnosis , urgent

fluoresceine angiography and intravitreal injection. IV injections

have become a huge cost burden and long term imposition on

patients and their carers.Gene therapy developed in Perth may offer

good control with less injections.Results in the first safety cohort

of 6 patients are now published. The proceedure has proven to be

convenient and safe. Results in our 27 active gene therapy cohort

and randomized 13 controls will be independantly analysed in May/

June 2015.

Bridging eye health divides with technology

A/Prof Angus Turner

A review of the latest telehealth applications helping bring

optometrists and ophthalmologists together to care for regional

towns. The imaging and technology applications will be discussed

with a series of clinical case presentations to demonstrate telehealth

and outline eye health management of common presentations.

Diagnosis and management of Fuch’s dystrophy and

endothelial failure

A/Prof Steve Wiffen

Causes of corneal endothelial failure will be discussed along with

management strategies and differential diagnosis. The pathogenisis

of Fuchs’ dystrophy will be discussed in detail.

Assessment and management of ptosis

Dr Jean-Louis deSousa

There are many causes of blepharoptosis, some associated with

serious and life threatening disease though most are a source of

mild visual and cosmetic symptoms. Treatment varies depending

on the cause and is not always surgical. An understanding of the

anatomy and physiology of the upper eyelid retractors forms the

basis of accurate assessment and management of blepharoptosis.

Diagnosis and management of Acanthameoba

Prof Geoffrey Crawford

Acanthamoeba can cause devastating visual complications and is

more commonly found in contact lens wearers in western countries.

This presentation will cover the differential diagnosis and possible

treatments.

Corneal dystrophies: diagnosis, differentials and management

Dr Andrea Ang

Corneal dystrophies are rare but understanding the management

options for patients is important.

(4)

Sunday 3 May 2015

McCusker Auditorium

Harry Perkins Institute

Program

7.45

12:00

Registration

Lunch

8:00

12:30

Bridging eye health divides with technology

A/Prof Angus Turner

Retinal vein occlusion: pathogenesis, treatments and trials

Prof Ian McAllister

Diagnosis and management of Fuch’s dystrophy and endothelial failure

A/Prof Steve Wiffen

“Doctor, what is wrong with my eye?”

A/Prof Mei-Ling Tay-Kearney

Assessment and management of ptosis

Dr Jean-Louis deSousa

Analysis of the optic nerve in glaucoma using OCT

Dr Vignesh Raja

Diagnosis and management of Acanthameoba

Prof Geoffrey Crawford

Gene therapy development in the context of wet macular degeneration

Prof Ian Constable

Corneal dystrophies: diagnosis, differentials and management

Dr Andrea Ang

Cataract and Glaucoma

Dr Antonio Giubilato

IOP - Myths, Truths, Interpretation and Management

Dr Antonia Giubilato

9:20

13:50

10:40

15:50

11:20

16:30

17:10

10:00

15:10

Cataract and Glaucoma

Dr Antonio Giubilato

Angle closure glaucoma has a number of  mechanisms- pupil

block, lens size,ciliary block and plateau iris . The lens/cataract has

an integral role in the pathogenesis of angle closure . The

inter-relationship between the role of the lens and other mechanisms

will be discussed and in particular the role of lens surgery in angle

closure will be put into context. In Open Angle Glaucoma especially

secondary causes e.g. Pseudo-exfoliation there remains a role for lens

surgery . Cataract surgery alone in glaucoma patients may result in a

small drop in IOP. After Trabeculectomy surgery significant rates of

cataract formation occur. Cataract surgery after glaucoma surgery can

result in glaucoma surgery failure . In open angle glaucoma cataract

surgery should not be

considered a treatment for glaucoma . However , The question “is my

patient better off having cataract surgery prior to glaucoma surgery ?”

should be asked.

IOP - Myths, Truths, Interpretation and Management

Dr Antonio Giubilato

Whilst IOP is no longer included in the definition of glaucomas

optic neuropathy it is integral in the management of glaucoma

as it remains the only modifiable risk factor. IOP measurement

is affected by numerous factors and the interpretation of “one

off IOP measurements “can be difficult . IOP can be measured

by different techniques with variable accuracy. The lowering of

IOP in glaucoma management should aim to slow the disease

by setting clinically appropriate target IOPs. A review of how to

measure IOP including the reliability of different instruments and

how IOP can vary with different ocular condition will be presented.

In addition the interpretation of “one off IOP readings “ in

glaucoma management will be discussed . The setting of clinically

achievable target pressures and how to interpret the adequacy of

management will evaluated

(5)

register online www.optomax.com.au

Dates & Time

Sunday 3 May 2015 8:00 - 17:50

Cost

Earlybird* $349

Full

$449

*earlybird pricing available for first 50 registrants only

Maximum CPD points are achieved by successful completion of

the assessment

Venue & Access

McCusker Auditorium

Harry Perkins Institute

QQ Block, Sir Charles Gairdner Hospital

6 Verdun Street, Nedlands WA 6009

Parking

Sir Charles Gairdner Hospital is well served by public

transport. Parking is available onsite.

How to Pay

Registrations are open online now at

www.optomax.com.au

Enquiries

Web:

www.optomax.com.au

Email:

[email protected]

Terms & Conditions

Terms and conditions apply, please see the

website for details.

Cancellations

If received more than 14 days prior to the event

a full refund less $50 administration fee is

applicable. After that date no refund is available.

Register

The Australian Institute of Optometry C o n f e r e n c e 2 0 1 1

References

Related documents

Importantly, our research showed for the first time that an intervention 18 19 21 22 designed to reduce smoking initiation in adolescents significantly weakened the impact of

As the whole rotor is modeled using the rigid finite element method, the crack is modeled by several spring-damping elements.. Similar to [ 17 ], the crack opening/closing is

Important potential adverse effects of omega-3 fatty acid supplementation include altered platelet function, gastrointestinal adverse effects, detrimental effects on wound healing,

During fiscal year 2009 (FY09), there were 19 freestanding psychiatric hospitals in Pennsylvania that treated 36.5% of the patients admitted for inpa- tient psychiatric care

While there is no requirement that an agent using the issuer- based pathway to display all Qualified Health Plans (QHPs) or to facilitate enrollment into all QHPs, CMS expects

The existing embedded software will utilize the remote control APIs to send state information of the device and to react to the remote control messages received.. Remote

You invoke an aspect to give yourself a bonus or make things a bit harder for your opponent. You can invoke any aspect that you a) know about, and b) can explain how you use it

Table 5 estimates the energy savings by switching to DC- inherent technologies run on AC power source and energy savings from avoided AC/DC power conversion losses [18-20]. We